Cargando…

Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker

OBJECTIVES: This post-trial data linkage analysis was to utilize the data of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants linked with their Medicare data to examine the risk of hospitalized and non-hospitalized gastrointestinal (GI) bleeding assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Xianglin L., Simpson, Lara M., Tandy, Brian C., Bettencourt, Judith L., Davis, Barry R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601451/ https://www.ncbi.nlm.nih.gov/pubmed/34793552 http://dx.doi.org/10.1371/journal.pone.0260107

Ejemplares similares

Risk of Developing Alzheimer’s Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up
por: Du, Xianglin L., et al.
Publicado: (2022)

Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT Ended
por: Du, Xianglin L., et al.
Publicado: (2021)

Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker: A Secondary Analysis of a Randomized Clinical Trial
por: Yamal, Jose-Miguel, et al.
Publicado: (2023)

The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT–Medicare linked data
por: Du, Xianglin L., et al.
Publicado: (2023)

Comments on ALLHAT and doxazosin
por: Krakoff, Lawrence R
Publicado: (2001)

Diuretic and β-Blocker in Hypertension—Then What?
por: Ramsay, L. E.
Publicado: (1980)

Impact of the ALLHAT Study Results on Managed Care
por: Anderson, Robert J.
Publicado: (2003)

Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT
por: Shahu, Andi, et al.
Publicado: (2019)

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
por: Piller, Linda B, et al.
Publicado: (2002)

A new era in hypertension research: discussing the findings of ALLHAT
por: Furberg, Curt D
Publicado: (2001)

Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid-lowering component of ALLHAT
por: Rahman, Mahboob, et al.
Publicado: (2013)

Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review
por: Brewster, Lizzy M, et al.
Publicado: (2013)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

Association between aspirin use and cardiovascular outcomes in ALLHAT participants with and without chronic kidney disease: A post hoc analysis
por: Desai, Niraj, et al.
Publicado: (2020)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Hospitalisations Related to the Combination of ACE Inhibitors and/or Angiotensin Receptor Blockers with Diuretics and NSAIDs: A Post Hoc Analysis on the Risks Associated with Triple Whammy
por: Mattioli, Irene, et al.
Publicado: (2023)

Prevention of Heart Failure in Hypertension—Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study
por: Johnson, Kyle, et al.
Publicado: (2019)

Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
por: Gavras, Irene, et al.
Publicado: (2001)

Antihypertensive Drug Effects on Renal Function and Myocardial Infarction and Implications of the ALLHAT Study Results
por: Curtiss, Frederic R.
Publicado: (2003)

Effect of ACE inhibitors and angiotensin receptor blockers on in-hospital mortality and length of stay in hospitalized COVID-19 patients
por: LaClair, Heather J., et al.
Publicado: (2021)

Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
por: Hooper, Philip L
Publicado: (2001)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study
por: Chiu, Michael H., et al.
Publicado: (2018)

Effect of dialysis modalities on risk of hospitalization for gastrointestinal bleeding
por: Huang, Chieh-Hsin, et al.
Publicado: (2023)

Decongestion: Diuretics and other therapies for hospitalized heart failure
por: Vazir, Ali, et al.
Publicado: (2016)

Length of hospital stay, diuretic dosing, and regression strategies
por: Çinier, Göksel, et al.
Publicado: (2019)

Diuretics
por: Servoss, George L.
Publicado: (1910)

Renal outcomes of diabetic patients treated with combination therapy of ACE inhibitors plus either thiazide diuretics or calcium channel blockers: comparative retrospective cohort study in Northwestern Ethiopia
por: Netere, Adeladlew Kassie, et al.
Publicado: (2021)

The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics
por: Wang, W, et al.
Publicado: (2011)

In-hospital acute upper gastrointestinal bleeding: What is the scope of the problem?
por: Haddad, Fady G, et al.
Publicado: (2019)

Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
por: Yamamoto, Eiichiro, et al.
Publicado: (2012)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
por: Volpe, Massimo, et al.
Publicado: (2012)

An algorithmic approach to gastrointestinal bleeding in patients receiving antithrombotic agents
por: Sadeghi, Amir, et al.
Publicado: (2020)

Diuretic Use Among Patients Receiving Hemodialysis in the United States
por: Flythe, Jennifer E., et al.
Publicado: (2022)

The incidence and risk factors analysis of acute kidney injury in hospitalized patients received diuretics: A single-center retrospective study
por: Zhang, Ruiqiu, et al.
Publicado: (2022)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
por: Yamamoto, Eiichiro, et al.
Publicado: (2013)

Predictors of In-hospital Mortality Among Patients Presenting with Variceal Gastrointestinal Bleeding
por: Kumar, Amith S., et al.
Publicado: (2015)

The Incidence and Mortality Impact of Gastrointestinal Bleeding in Hospitalized COVID-19 Patients
por: Makker, Jasbir, et al.
Publicado: (2021)

Outcomes of Upper Gastrointestinal Bleeding in Hospitalized Patients With Generalized Anxiety Disorder
por: Kaye, Alexander J, et al.
Publicado: (2022)

Lower gastrointestinal bleeding in a patient receiving sevelamer: Case report
por: Schoot, Tessa S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjeasgrfegvpvuqk81l2kf07dj